Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.
about
Vitiligo: interplay between oxidative stress and immune systemA case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat.Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibilityEffect of in vitro and in vivo anakinra on cytokines production in Schnitzler syndrome.Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibilityDifferential responses of normal human melanocytes to intra- and extracellular dsRNATumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo.Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligoEvaluation of the Efficacy of Topical Tetracycline in Enhancing the Effect of Narrow Band UVB against Vitiligo: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.The role of tumor necrosis factor-α in the pathogenesis of vitiligo.The association between tumor necrosis factor-α-308 G/A polymorphism and risk for vitiligo: a meta-analysis.Advances in the treatment options for vitiligo: activated low-dose cytokines-based therapy.Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.Genetic variants of interferon-gamma and its mRNA expression and inflammatory parameters in the pathogenesis of vitiligo.Role of chemokines and the corresponding receptors in vitiligo: A pilot study.Associations of TNF-α -238 A/G and IL-10 -1082 G/A Genetic Polymorphisms With the Risk of NONFH in the Chinese Population.IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo.Decreased regulatory T-cells and CD4(+) /CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo.New onset vitiligo following commencement of infliximab in Crohn disease.Improvement of vitiligo in a patient with rheumatoid arthritis after hydroxychloroquine treatment.Tumor Necrosis Factor Alpha Gene Polymorphism and Association With Its Serum Level in Iranian Population with Rheumatoid Arthritis
P2860
Q26824504-F604319D-DDD9-461E-95F0-66DAAE77A75AQ33897820-C23713B0-B143-47D4-BB5A-402AD03EB870Q34183603-82A23428-DC24-4FAD-9464-1B02ECB95748Q34635020-F0CD612D-3839-4822-BA8A-8200D651BACFQ35060678-F48FA5B5-25E6-42E8-9159-3AB9A5C7E692Q35799552-E8EE1B23-D278-4443-AD2E-AB04A3B38C50Q36094915-56CADD8D-93B6-4AE4-AB93-FFEDDF8D34B7Q37271641-57DF7E4F-0232-4FEC-ACC0-0E14DAC3E183Q37602759-E7AB2CA7-596C-4AF7-ABE4-069E3674C4F5Q38126326-F1B0DCB7-3C8A-4064-AF12-2E69DD98E1C2Q38388080-F0E901B2-1511-497C-8082-5951432698B7Q38587330-92EB83A3-E04C-46C4-AC4C-99D58F0016C2Q40072169-7BA0A8BC-2DBE-41AE-8FEC-395EEE28BC80Q45980503-7B1C1FC7-E420-41CF-A184-4F69AC7709EDQ46490608-5A111C38-E546-42BE-BBFE-33B4B04DBC3CQ47426230-AF08448F-44D7-4647-9F3E-F60D8C7B04B3Q48098753-88518089-54D1-4B6D-9CF1-D067C0BAC239Q50787510-ED062AA2-2873-4311-86AA-E0BF34874C31Q51075988-61BF92AE-CE1B-4011-AD5F-33E322768396Q53123158-CF1CA68D-C42C-4310-9985-873647D019DBQ53258966-8CC73537-4223-4D39-8D6F-FB58712DBC43Q58134794-D752A06A-7DBE-4505-B4B3-040C45B7B859
P2860
Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Increased Tumor Necrosis Facto ...... sceptibility towards vitiligo.
@ast
Increased Tumor Necrosis Facto ...... sceptibility towards vitiligo.
@en
Increased Tumor Necrosis Factor
@nl
type
label
Increased Tumor Necrosis Facto ...... sceptibility towards vitiligo.
@ast
Increased Tumor Necrosis Facto ...... sceptibility towards vitiligo.
@en
Increased Tumor Necrosis Factor
@nl
prefLabel
Increased Tumor Necrosis Facto ...... sceptibility towards vitiligo.
@ast
Increased Tumor Necrosis Facto ...... sceptibility towards vitiligo.
@en
Increased Tumor Necrosis Factor
@nl
P2860
P1433
P1476
Increased Tumor Necrosis Facto ...... sceptibility towards vitiligo.
@en
P2093
Naresh C Laddha
P2860
P304
P356
10.1371/JOURNAL.PONE.0052298
P407
P577
2012-12-20T00:00:00Z